Xiaobin Wu Sells $337K of BeiGene Ltd (BGNE) — SEC Form 4, Jun 20, 2023

Open-Market Net Sale · SEC Form 4
−$337,356

Equity position changed by +23.4%

Reporting Owner
Xiaobin Wu
COO
TXN 2023-06-20 · FILED 2023-06-20
Equity Position 1.05M sh 851,103 → 1,049,797
Equity Change +23.4% shares held after vs before
Filing Lag 0 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

BeiGene Ltd

BGNE CIK 0001651308
All BeiGene Ltd insider activity
Filing Date
2023-06-20
Report Date
2023-06-15
Accession No.
0001651308-23-000090
Accepted At
2023-06-20 22:49 UTC
Reporting Owner
Name Relationship
Xiaobin Wu CIK 0001739452
COO
Xiaobin Wu at BeiGene Ltd Full insider history
Bought (12 mo) —
Sold (12 mo) $8,753,697
More from this insider at BeiGene Ltd
2026-08-27 Sell -$106,400 View
2026-06-25 Sell -$356,927 View
2026-06-18 Sell -$361,997 View
2026-06-15 Sell -$163,512 View
2026-06-10 Sell -$399,738 View
All filings by this insider at BeiGene Ltd
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Ordinary SharesF1 2023-06-15 A - Award/Grant 200,447 A $0.00 — 1,033,432 Direct
American Depositary SharesF2F6F7 2023-06-20 S - Sale 1,753 D $192.44 -$337,356 0 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Share Option (Right to Buy)F8F8F9 $16.41 2023-06-15 A - Award/Grant 760,851 A $0.00 2033-06-14 760,851 Ordinary Shares Direct
Non-Derivative Holdings
Title Shares Held Ownership
American Depositary SharesF2 12,365 Direct
American Depositary SharesF2 4,000 Indirect
RMB SharesF3F4F5F5 0 Indirect
Footnotes (9)
F1
Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Show more
F2
Each American Depositary Share represents 13 Ordinary Shares. Show more
F3
The term "RMB Shares" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange (the "STAR Offering"), to permitted investors in Renminbi ("RMB") within the People's Republic of China ("PRC") in accordance with the rules of the STAR Market. Show more
F4
The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924). Show more
F5
The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose. Show more
F6
The sale was effected pursuant to mandatory tax withholding provisions in the Reporting Person's restricted share unit award agreements in connection with the vesting of two restricted share unit awards previously granted to the Reporting Person. 1/4th of the securities under one award will vest on each anniversary of June 17, 2020 and under the other award on each anniversary June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Show more
F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.41 to $192.61, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
F8
The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Show more
F9
These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. Show more

Related filings at BeiGene Ltd

Institutional Holders
13F holders · Jun 30, 2026 283 institutional managers reporting a position
Largest by reported value
  1. Baker Bros. Advisors Lp $2.51B
  2. Primecap Management Co/Ca/ $1.43B
  3. Capital International Investors $1.2B
5%+ Holders · 13D/G 2 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at BeiGene Ltd
All BeiGene Ltd insider activity
GET /v1/forms/4/0001651308-23-000090 API docs
View Original SEC Filing